CCTV News released the news on December 20, the China Food and Drug Administration has approved China's first special drug that can resist the new crown virus on the market, and the use of this special drug is extremely simple, only need to put the agent in normal saline, and then intravenous injection is good, this special drug has two bottles of injection, so intravenous injection of two bottles of medicine can be, and after the drug enters the body can immediately play a protective role, the effect is immediate, the whole process only needs 40 minutes. And according to the introduction of the R&D leader, in the face of the emerging virus, it is very convinced of the inhibition ability of this special drug.
Covid-19 special drug
According to CCTV news, the China Food and Drug Administration has approved the listing of China's first special drug that can resist the new crown virus, and Zhang Linqi is the "leader" of the special drug research team. This special drug has two bottles of injection, the blue label is amphavir monoclonal antibody, the red label is romibimab, the dosage method of the special drug is particularly simple, there are two bottles, now put one of them in normal saline, intravenous injection on the line, drip a bottle, and then infuse another bottle of medicine, just like the common cold drip injection.
It takes about 40 minutes to completely inject the drug, and immediately after the injection is completed, it will provide protection for the body, the effect is immediate, and according to clinical trials, this special drug can reduce the hospitalization rate and mortality rate of the new crown by 80%, and the drug will have a "shelf life" of 9 to 12 months in the human body, and it can also have a preventive effect on the new crown virus. Does this mean that this could really be the last winter to fight the pandemic?
Valid for Omikeron
The research team of the specific drug started with antibodies and wanted to find the strongest antibody to prevent the virus from binding to the cell, so that the virus could not replicate in the human body. In Zhang Linqi's introduction, we learned that in the antibodies produced by the human body, not every antibody can resist the virus, so to find the strongest and most effective antibody, and then amplify its role, you can target the virus.
Is that still effective against mutated strains? In 2020, when the virus mutates for the first time, the scientific research team is also out of a cold sweat, but immediately according to the process of virus mutation, the antibody is evaluated, there is no problem, every time the virus mutation will be evaluated, to see if the antibody will be inactivated, but in the end there is no inactivation, or have anti-viral activity, so the face of Aumicjong is also very confident.
When it will be fully marketable
The drug has been successfully brought to market, but it will take a while, not too long, maybe a few days, a few weeks. Technical teams, government departments and regulators are working around the clock. And the research team will continue to work on antibodies that may be more effective and better, as well as antibodies that can be used as "alternatives" to prevent failure.
According to Luo Yongqing, CEO of Tengsheng Huachuang, in the face of overseas, the government procurement price of special drugs is 2100 US dollars. At present, the number of deaths due to the new crown in the United States has exceeded 800,000, but according to US media reports, the people in the United States are still "free travel", and the number of security checks at airports for three days exceeds 20 million. When foreign social problems are frequent and the epidemic is difficult to control, the emergence of Special Drugs in China can be said to be the dawn in the dark.